Last updated: 2026-10-13 09:22:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Quanome Technologies, Inc. (QNME) operates in the ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO sector and is listed on NASDAQ. The stock is currently priced at $0.58, with a market capitalisation of $25.53M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.26 to $1.40. This page covers its latest market performance, valuation, price trends and company information.
$25.53M | |
$0.58 | |
$1.40 | |
$0.26 | |
$0.56 | |
47.67K | |
18.44M | |
-- | |
$1.40 | |
$0.26 | |
-- | |
-- |
Quanome Technologies, Inc. (QNME) is trading at $0.58 in pre-market trading as of 2026-10-13 09:21:00, up 3.55% ($0.02) from the previous close of $0.56
Pre-market trading shows how investors are pricing QNME before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Quanome Technologies, Inc. (QNME) moved from $0.56 to $0.58, representing a gain of 3.57% ($0.02).
The stock traded between $0.50 and $0.94 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 14.84 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 28.0%
QNME is currently trading at $0.58, placing it 28.0% of the way from its 52-week low of $0.26 to its 52-week high of $1.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.
| Industry | ARRANGEMENT OF TRANSPORTATION OF FREIGHT & CARGO |
| Employees | 27 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Quanome Technologies, Inc. (QNME) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.